🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main goal of this research study is to determine how nivolumab and nivo...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-09-02
Trial ID
NCT04401995
Treatments Being Tested
This is an open-label, randomized, window-of-opportunity phase 2 clinical s...
Status
Active Not Recruiting
Location
CHUV Oncology Department
Start Date
2021-04-07
Trial ID
NCT04807192
Treatments Being Tested
This is a Phase 1b/2 dose-optimization study to evaluate safety, pharmacoki...
Status
Terminated
Location
UCSD Medical Center - Encinitas
Start Date
2015-11-09
Trial ID
NCT02554812
Treatments Being Tested
CMP-001-011 is a Phase 2/3 study of CMP-001 intratumoral (IT) and nivolumab...
Status
Terminated
Location
Mayo Clinic Arizona
Start Date
2021-02-24
Trial ID
NCT04695977
This study will be conducted in two parts: Part 1 will be conducted using a...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2016-04-12
Trial ID
NCT02680184
Treatments Being Tested
CMP-001-010 is a Phase 2 study of CMP-001 intratumoral (IT) and nivolumab i...
Status
Terminated
Location
Mayo Clinic
Start Date
2021-03-11
Trial ID
NCT04698187
The purpose this research study is to determine if the combination of nivol...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2018-08-08
Trial ID
NCT03618641
The goal of this study is to learn if giving cemiplimab and vidutolimod tog...
Status
Terminated
Location
University of Alabama
Start Date
2021-11-30
Trial ID
NCT04916002
Treatments Being Tested
A single institution study to evaluate the safety and tolerability of the c...
Status
Completed
Location
Sheba Medical Center
Start Date
2018-12-15
Trial ID
NCT03507699
Treatments Being Tested
This phase II trial tests whether vidutolimod with nivolumab works to destr...
Status
Suspended
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2023-06-07
Trial ID
NCT05445609
Treatments Being Tested